Natalie E. Stevens

641 total citations
18 papers, 440 citations indexed

About

Natalie E. Stevens is a scholar working on Immunology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Natalie E. Stevens has authored 18 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Natalie E. Stevens's work include Immune Response and Inflammation (4 papers), Advanced Glycation End Products research (3 papers) and Influenza Virus Research Studies (2 papers). Natalie E. Stevens is often cited by papers focused on Immune Response and Inflammation (4 papers), Advanced Glycation End Products research (3 papers) and Influenza Virus Research Studies (2 papers). Natalie E. Stevens collaborates with scholars based in Australia, Slovakia and United Kingdom. Natalie E. Stevens's co-authors include John D. Hayball, Kerrilyn R. Diener, Marianne J. Chapman, Cara K. Fraser, Katherine E. S. Locock, Hans J. Griesser, Matthias Haeussler, Almar Postma, Krasimir Vasilev and Thomas D. Michl and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Natalie E. Stevens

18 papers receiving 438 citations

Peers

Countries citing papers authored by Natalie E. Stevens

Since Specialization

Citations

This map shows the geographic impact of Natalie E. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie E. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie E. Stevens more than expected).

Fields of papers citing papers by Natalie E. Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie E. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie E. Stevens. The network helps show where Natalie E. Stevens may publish in the future.

Co-authorship network of co-authors of Natalie E. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie E. Stevens. A scholar is included among the top collaborators of Natalie E. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie E. Stevens. Natalie E. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Acute urinary tract infection elicits bladder afferent hypersensitivity 2025 ·Brain Behavior & Immunity - Health ·(unknown), Sarah K Manning, Natalie E. Stevens, (unknown), Feargal J. Ryan, (unknown), Sonja Klebe, Geraint B. Rogers, Miriam A. Lynn, Steven Taylor, Luke Grundy	1
2	Diet at birth is critical for healthy growth, independent of effects on the gut microbiota 2024 ·Microbiome ·(unknown), Akila Rekima, Miriam A. Lynn, (unknown), (unknown), (unknown), (unknown), A.M. Middleton, Natalie E. Stevens, Florence Servant, Rémy Burcelin, David J. Lynn, Valérie Verhasselt	5
3	Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial 2024 ·EBioMedicine ·Nicole L. Messina, Susie Germano, Rebecca McElroy, (unknown), Branka Grubor‐Bauk, David J. Lynn, Ellie McDonald, Suellen Nicholson, Kirsten P. Perrett, Laure F. Pittet, Rajeev Rudraraju, Natalie E. Stevens, Kanta Subbarao, Nigel Curtis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
4	Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice 2021 ·Vaccine ·Natalie E. Stevens, (unknown), (unknown), Feargal J. Ryan, Byron Brook, Nelly Amenyogbe, Helen Marshall, Miriam A. Lynn, Tobias R. Kollmann, Damon J. Tumes, David J. Lynn	8
5	The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota 2021 ·Cell Reports Medicine ·Stephen J. Blake, (unknown), Feargal J. Ryan, José A. Caparrós‐Martín, Georgina L. Eden, (unknown), (unknown), Saoirse C. Benson, Damon J. Tumes, (unknown), Natalie E. Stevens, John Finnie, Hiroki Kobayashi, Deborah L. White, Steve Wesselingh, Fergal O’Gara, Miriam A. Lynn, David J. Lynn	26
6	Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin 2019 ·Frontiers in Immunology ·Natalie E. Stevens, Allison J. Cowin, Zlatko Kopecki	21
7	High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care support 2019 ·Experimental and Therapeutic Medicine ·Natalie E. Stevens, (unknown), Cara K. Fraser, Tim Kuchel, Matthew J. Maiden, Marianne J. Chapman, Kerrilyn R. Diener, John D. Hayball	1
8	Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease 2018 ·Frontiers in Immunology ·Zlatko Kopecki, Natalie E. Stevens, Heng Thay Chong, (unknown), Allison J. Cowin	15
9	Recombinant Leucine-Rich Repeat Flightless-Interacting Protein-1 Improves Healing of Acute Wounds through Its Effects on Proliferation Inflammation and Collagen Deposition 2018 ·International Journal of Molecular Sciences ·Zlatko Kopecki, Natalie E. Stevens, (unknown), Elizabeth Melville, Allison J. Cowin	9
10	Overcoming the challenges of topical antibody administration for improving healing outcomes: a review of recent laboratory and clinical approaches. 2017 ·Adelaide Research & Scholarship (AR&S) (University of Adelaide) ·Natalie E. Stevens, Allison J. Cowin	3
11	Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes 2017 ·Scientific Reports ·Natalie E. Stevens, Marianne J. Chapman, Cara K. Fraser, Tim Kuchel, John D. Hayball, Kerrilyn R. Diener	90
12	CoVaccine HT™ adjuvant is superior to Freund's adjuvants in eliciting antibodies against the endogenous alarmin HMGB1 2016 ·Journal of Immunological Methods ·(unknown), Natalie E. Stevens, Kerrilyn R. Diener, John D. Hayball	12
13	Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection 2016 ·Scientific Reports ·Natalie E. Stevens, (unknown), Cara K. Fraser, Mohammed Alsharifi, Kerrilyn R. Diener, John D. Hayball	9
14	Depletion of high‐affinity corticosteroid‐binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications 2014 ·Clinical Endocrinology ·(unknown), Wayne Rankin, Marianne J. Chapman, Natalie E. Stevens, Kerrilyn R. Diener, John D. Hayball, John G. Lewis, David J. Torpy	45
15	RAFT-derived antimicrobial polymethacrylates: elucidating the impact of end-groups on activity and cytotoxicity 2014 ·Polymer Chemistry ·Thomas D. Michl, Katherine E. S. Locock, Natalie E. Stevens, John D. Hayball, Krasimir Vasilev, Almar Postma, Yue Qu, Ana Traven, Matthias Haeussler, Laurence Meagher, Hans J. Griesser	66
16	Antimicrobial Polymethacrylates Synthesized as Mimics of Tryptophan-Rich Cationic Peptides 2014 ·ACS Macro Letters ·Katherine E. S. Locock, Thomas D. Michl, Natalie E. Stevens, John D. Hayball, Krasimir Vasilev, Almar Postma, Hans J. Griesser, Laurence Meagher, Matthias Haeussler	94
17	An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT™ Is Functionally Superior to Freund's Adjuvant 2013 ·PLoS ONE ·Natalie E. Stevens, Cara K. Fraser, Mohammed Alsharifi, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball	8
18	Xenografts — future prospects for clinical transplantation 1991 ·Immunology Letters ·Thomas Cairns, David Taube, Natalie E. Stevens, R M Binns, Ken I. Welsh	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact